Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment
Aclarion added Lanman Spinal Neurosurgery, a high-volume private practice in Beverly Hills, as a clinical site for its ongoing CLARITY trial evaluating Nociscan. The inclusion of a private practice site is designed to accelerate enrollment in the 300-patient randomized study, which targets an initial public disclosure of early interim results in Q4 2026.
Key figures
- Drug Name
- Nociscan
- Phase Of Trial
- Randomized clinical trial
- Surgical success rate
- 97%
- Interim readout timeline
- Q4 2026
- Patient enrollment target
- 300
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.